Expression of aquaporin 4 and Kir4.1 in diabetic rat retina: Treatment with minocycline

56Citations
Citations of this article
40Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This study examined aquaporin 4 (AQP4) and Kir4.1 (a potassium channel subunit) in normal and diabetic adult Sprague- Dawley rats, and determined the effect of minocycline treatment. Retinal expression of the AQP4 and Kir4.1 genes was examined using double immuno fluorescence, Western blot analysis, and real-time reverse transcription-polymerase chain reaction. Retinal levels of vascular endothelial growth factor (VEGF), ionized calciumbinding adaptor molecule (Iba)-1 and interleukin (IL)-1β were also ascertained. The blood-retinal barrier (BRB) and retinal oedema were assessed using rhodamine isothiocyanate. AQP4, VEGF, Iba-1, and IL-1β mRNA and protein levels increased, and Kir4.1 mRNA and protein levels decreased, in diabetic rat retinas. Both BRB disruption and retinal oedema were also observed in these retinas. In diabetic rats, minocycline treatment decreased AQP4, VEGF, Iba-1 and IL-1β levels and retinal oedema, and increased Kir4.1 levels. These findings suggest that minocycline might be beneficial for retinal fluid clearance and reduction of retinal oedema in diabetic retinopathy. © 2011 Field House Publishing LLP.

Cite

CITATION STYLE

APA

Zhang, Y., Xu, G., Ling, Q., & Da, C. (2011). Expression of aquaporin 4 and Kir4.1 in diabetic rat retina: Treatment with minocycline. Journal of International Medical Research, 39(2), 464–479. https://doi.org/10.1177/147323001103900214

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free